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S u m m a r y  
 
Malfunctioning of environmental, immunologic or 
genetic mechanisms brings about a disorder of system 
homeostasis, which results in the development of diseases of 
arduous course. Inflammatory bowel diseases are a group of 
disorders which house a pathological inflammation of the 
wall of the gastrointestinal tract. It is postulated that one 
reason for the resulting changes may be free radical 
reactions. As a result of the ongoing inflammation under the 
course of the disease an influx of neutrophils into the lumen 
begins. Although endoscopic examination constitutes an 
irreplaceable method in the evaluation of the resulting 
changes, laboratory tests are an essential tool in the 
diagnostic process. In recent years it has been proven that the 
role of faecal calprotectin as a non-invasive test can be used 
to differentiate organic and functional gastrointestinal 
diseases, and evaluate remission or exacerbation of 
inflammatory bowel disease [6,28]. It has also been noted 
that there is a need to seek other new markers that would 
facilitate the diagnosis. 
 
S t r e s z c z e n i e  
 
W wyniku nieprawidłowego działania mechanizmów 
środowiskowych, immunologicznych czy genetycznych 
dochodzi do zaburzenia homeostazy ustrojowej, co skutkuje 
rozwojem chorób o uciążliwym przebiegu. Nieswoiste 
zapalenia jelit stanowią grupę schorzeń, w których dochodzi 
do patologicznego zapalenia ściany przewodu pokarmowego. 
Postuluje się, iż jedną z przyczyn powstałych zmian mogą 
być reakcje wolnorodnikowe. W wyniku toczącego się 
procesu zapalnego w przebiegu tych chorób rozpoczyna się 
napływ neutrofilów do światła jelita. Mimo, iż niezastąpioną 
metodą w ocenie powstałych zmian jest badanie 
endoskopowe, badania laboratoryjne stanowią niezbędne 
narzędzie w procesie diagnostycznym. W ostatnich latach 
udowodniona jest rola kalprotektyny kałowej, jako 
nieinwazyjnego badania służącego do różnicowania 
organicznych i czynnościowych chorób przewodu 
pokarmowego, oceny remisji bądź zaostrzenia nieswoistego 
zapalenia jelit [6,28]. Wskazuje się także na potrzebę 
poszukiwania innych nowych markerów, które przyczyniłyby 
się do ułatwienia diagnostyki. 
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Inflammatory bowel diseases (Inflammatory Bowel 
Diseases) are a group of chronic diseases of the 
gastrointestinal tract, which includes Crohn's disease 
and ulcerative colitis [25]. The above-mentioned 
diseases are characterized by the occurrence of periods 
of remission and exacerbation. The ethology of 
inflammatory bowel disease is not fully understood. 
Currently, the role of genetic factors (genes located on 
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chromosomes: 1, 5, 6, 12, 14, 16 and 19 are pinpointed 
as taking part), environmental, immunological 
disorders, viral or bacterial infections have been 
indicated [2, 43, 44].  
Among the environmental factors, the role of 
trauma or abnormal response to stress is noted [10]. 
Due to the ongoing inflammation in the intestine, it is 
suggested that one of the causes of these diseases may 
be free radical reactions that lead to the development of 
the phenomenon referred to as oxidative stress [25]. 
Then, it leads to an oxidant-antioxidant imbalance, 
which results in the overproduction of reactive oxygen 
species (ROS) and the dominance of the oxidation 
reaction [16]. The oxidative stress leads to oxidation of 
cell membranes, changes in the structure and function 
of proteins, or DNA damage [23]. The oxidative stress 
also leads to lipid peroxidation, which is a process of 
oxidation of unsaturated fatty acids, leading to the 
formation of peroxides of such compounds. The main 
product of lipid peroxidation is malondialdehyde 
(MDA), the concentration of which, under the 
conditions of increased production of ROS, increases 
and causes a change in the permeability of the cell 
membrane [20]. 
The large intestine undergoes colonization by a 
very large number of bacteria that continuously 
stimulate the GALT system (Gut Associated Lymphoid 
Tissue) making a distinction between the symbiotic 
bacterial flora and the pathological one. When it comes 
to recognizing and destroying pathogenic organisms 
the so-called intestinal homeostasis is maintained.  
Then, the intestinal microflora and the GALT remain 
in balance. The tightness of the intercellular 
connections and the presence of a mucus layer ensure 
proper operation of GALT [25]. On the other hand, the 
intercellular damage is caused by hydrogen peroxide 
produced by colonocytes [32]. As a result of this 
process, the bacteria pass into the lamina propria, T 
cell stimulation and production of proinflammatory 
cytokines are initiated [33]. In the course of 
inflammatory bowel disease one can observe an 
increased number of T and B cells, mast cells, 
monocytes or macrophages. Among the latter, two 
types of M1 and M2 can be recognized.  
It is the M1 type macrophages that play an 
important role in initiating and sustaining the 
inflammation.  
They generate free radicals, an inducible nitric 
oxide synthase (iNOS), IL-12 or TNF-α [11]. 
An increase of leukocytes polymorphic nucleus 
(PMNs) in the lamina propria, which release large 
quantities of such proteases: elastase, cathepsin G or 
collagenase, is of great importance in the course of 
inflammatory bowel disease [14]. The effect of the 
above proteases leads to leakage junctions. Gouna-
Berthold et al. observed increased concentrations of 
leukocyte elastase in the plasma of patients with 
ulcerative colitis. Furthermore, they proved that the 
concentration of the enzyme correlates with disease 
activity [13]. In turn, Kuno et al. demonstrated that 
elastase deriving from neutrophils affects the cell 
proliferation, and consequently interferes with repair 
processes in the intestinal mucous membrane layer 
[21]. And in the research of Gouna-Berthold et al. [13] 
it was demonstrated that plasma elastase is a useful and 
independent indicator of the activity of inflammatory 
bowel disease. The increased activity of proteases is 
also reinforced by a fall in concentrations of protease 
inhibitors. In the serum the main inhibitor of the serine 
protease is α1-antitrypsin, which protects the body 
from damage accompanying the inflammatory process 
[37]. 
α-1 antitrypsin is a glycoprotein which has a 
molecular weight of about 52 kDa. It is built of a single 
polypeptide chain comprising 394 amino acid residues. 
In its spatial structure we can discern nine domains of 
the α-helix structure and three β-bead [7.22]. At the 
carboxy terminal the domain is present, which 
comprises the following sequence of amino acids: 
proline, methionine, serine and isoleucine. It is the 
presence in the sequence of methionine at the 358 
position of the polypeptide chain that is the cause of 
inactivation of the elastase-α by 1 antitrypsin [5]. 
α1-antitrypsin is synthesized primarily in the liver 
[39] and, in smaller quantities, also in monocytes, 
macrophages, intestinal epithelial cells and bowel. It 
strongly reacts with neutrophil elastase [19]. 
Determination of the concentration of the resulting 
complexes in serum or plasma can be used to assess 
the activity of inflammation and provide information 
on the stimulation of neutrophils in the inflammation 
focus. The α-1 antitrypsin is a recognized protein of an 
acute phase denoted in the blood, and has a relatively 
low susceptibility to damage caused by enzymes. 
Therefore, its amount determined in the feces reflects 
the actual concentration of the protein. Elevated levels 
of α1-antitrypsin indicate an increase in the 
permeability of the intestinal membrane. It also 
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constitutes an indicator of intestinal loss of protein 
[38]. 
In order to destroy the bacteria, the leukocytes of 
polymorphic nucleus produce reactive oxygen species 
such as the hydroxyl radical, superoxide anion or 
hypochlorite [3.31]. The resulting superoxide anion 
that occurs in neutrophils can also be generated by 
cells of the large intestine [30]. Superoxide anion and 
hydrogen peroxide can oxidize phospholipids of cell 
membranes. Additionally, the hydrogen peroxide may 
react with iron ions in the course of Fenton reaction, 
which leads to the formation of the hydroxyl radical. 
This, in turn, may lead to depolymerization of mucous 
cells in the colon; thus, to a damage to the natural 
intestinal barrier. This hydroxyl radical rapidly reacts 
with the cell membrane lipids, some of the side groups 
of amino acids and DNA, leading to the destruction of 
cell membrane and the formation of mutations [31]. 
Another compound with a high reactivity is the 
hypochlorite, produced by the myeloperoxidase (MPO) 
from activated neutrophils. It is under the influence of 
MPO that the hydrogen peroxide is transformed to 
hypochlorite [29], which can oxidize DNA, thiol 
groups, purine and pyrimidine nucleotides, 
polyunsaturated fatty acids or aromatic amino acids 
[37]. 
MPO is a protein indicator of a molecular weight of 
140 kDa [12]. It is present in the granules of 
neutrophils and is released during the acute phase 
during the inflammatory condition. MPO, due to the 
catalysed reaction, is involved in an oxygen-dependent 
antimicrobial activity. Its determination in the stool can 
reflect inflammation in Crohn's disease or ulcerative 
colitis. 
The formation of ROS, in addition to the MPO 
mentioned above, also involves such enzymes as: 
NADPH oxidase and inducible nitric oxide synthetase 
(iNOS) [34]. NADPH oxidase catalyses one-electron 
reduction of oxygen to superoxide anion. In the course 
of inflammatory bowel disease the concentration of 
nitric oxide (NO) increases as a result of increase of 
iNOS activity [25]. Keshavarzian et al. showed in their 
study a positive correlation between the level of NO 
and activity of the disease. Further they noted that, in 
the course of ulcerative colitis the nitric oxide 
concentration is higher than in Crohn's disease [15]. 
The migration of leukocytes and the phase of 
exacerbation of the disease is also caused by the 
production of Interleukin-8 (IL-8) [27] by neutrophils 
of proinflammatory cytokines. Neutrophils, in their 
granules, contain significant quantities of serine 
proteases including lysozyme, peroxidase, or free 
radicals, which once released, amplify their 
inflammatory response [11]. It is worth noting that 
increasing concentrations of ROS bring about lowering 
the level of antioxidants, which act as "scavengers" of 
reactive oxygen species [34]. Among the most 
important antioxidant systems, preventing free radical 
damage, are mentioned: superoxide dismutase (SOD), 
catalase (CAT), reductase (GR), glutathione peroxidase 
(GPx) and glutathione S-transferase (GST). These 
enzymes form a coherent system for protecting 
antioxidant. The role of superoxide dismutase is the 
dismutation of superoxide anion into oxygen and 
hydrogen peroxide which is then decomposed with the 
involvement of catalase and peroxidase to water and 
molecular oxygen.  
In people with inflammatory bowel disease, a lower 
SOD activity has been shown as compared to healthy 
subjects. This enzyme activity was measured in 
plasma, biopsies and neutrophils, which originated 
from the cell culture [1,3,42]. 
The decrease in SOD activity leads to excessive 
accumulation of superoxide anion. On the other hand, 
Mulder et al. demonstrated a reduction in the SOD 
activity in the inflamed mucosa of patients, but the 
enzyme activity in the intact mucosa inflammation was 
comparable to the activity of SOD in healthy subjects. 
Researchers have also observed no significant 
difference between the activity of the enzyme in 
patients with Crohn's disease and ulcerative colitis 
[26]. However, in research by Oshita et al. [30] we did 
not observe any difference in the activity of SOD in the 
inflamed mucosa compared to healthy areas of mucosa 
in patients and compared to healthy subjects. The 
process of neutralization of hydrogen peroxide, which, 
as previously mentioned, is produced by colonocytes, 
the following are involved: catalase, and glutathione 
peroxidase. This, in turn, its operation requires reduced 
glutathione [34]. Ruan et al. observed no significant 
difference between the levels of glutathione in the 
mucosa in patients with active forms of Crohn's disease 
and ulcerative colitis. By contrast, during the Crohn's 
disease in its remission there were observed higher 
glutathione levels as compared to the active phase of 
the disease [35]. The concentration of glutathione is 
regulated with the participation of γ-glutamylcysteine 
synthetize and glutathione reductase, which increase its 
concentration. On the other hand, γ-glutamyl 
transpeptidase and glutathione oxidase lead to a 
Daria Kupczyk et al. 
 
46 
reduction in glutathione levels. Under conditions of 
oxidative stress due to the action of glutathione 
peroxidase, an oxidized form of glutathione, which is 
glutathione disulphide, is formed. If it does not 
undergo any re-reduction, it will go into the cytoplasm 
where it accumulates.  
And the preferred glutathione escape from a cell is 
facilitated by the fact that the cell membrane is easily 
permeable to oxidized glutathione [35]. 
These data prove that the antioxidant enzymes, both 
directly and indirectly, are involved in the free radicals 
reactions, creating an integrated defence system of the 
body [36]. Determination of their activity in the serum 
or in biopsies, in the course of inflammatory bowel 
disease, can provide a lot of valuable information about 
the state of the body's antioxidant barrier. Furthermore, 
it can be used both for diagnosis, prognostic and 
preventive. 
So far, it has not been proven that there is a 
sufficiently effective diagnostic laboratory test, which 
would allow differentiation between the Crohn's 
disease and the ulcerative colitis. Inflammatory bowel 
diseases, particularly ulcerative colitis, is characterized 
by the presence of infiltration of neutrophils and 
eosinophils. Therefore, attempts are made to assess the 
suitability of the diagnostic signs of substances 
secreted by neutrophils. Apart from the above 
mentioned elastase, calprotectin is also belongs to the 
acute phase proteins. Calprotectin is a heterodimer. In 
its construction, there are two subunits of S100A8 and  
two subunits of S100A9, of the size of 8 and 14 kDa 
respectively (MRP8 / MRP14 [18]. Calprotectin binds 
the Ca 2+ and Zn 2+ ions. This represents 
approximately 50-60% of soluble cytoplasmic protein 
neutrophils [9]. In small quantities, it is also present in 
monocytes and macrophages [4]. It plays a regulatory 
role in the inflammation process. It also has anti-
microbial, anti-fungal or antiproliferative properties on 
some tumour lines [41]. There is also a chemotactic 
factor for neutrophils [10 ]. The bactericidal properties 
of calprotectin result from inhibition of bacterial zinc-
dependent metalloproteinases. Calprotectin is released 
during the activation or cell death. By binding of 
calcium ions it is resistant to proteolytic degradation or 
by colonic bacteria and therefore, it proves stable in 
feces, even for few days [18].  
As mentioned earlier in patients with inflammatory 
bowel disease there is a loss of containment of the 
intestinal barrier and the intensification of leukocyte 
migration through the intestinal wall, resulting in 
increased release of calprotectin to faeces [40]. Since 
one of the elements of the pathogenesis of 
inflammatory bowel disease is an inflammatory 
infiltration in the intestinal wall, which contains inter 
alia neutrophils, it can be concluded that the 
concentration of calprotectin in these patients will be 
higher. Thus, it may be a marker of intestinal 
inflammation. So far, studies have confirmed this 
hypothesis because the concentration of calprotectin in 
the faeces of patients with inflammatory bowel disease 
is higher than in patients with functional bowel disease 
and in healthy individuals [6,8,28]. 
Inflammatory bowel diseases are a group of 
diseases in the course of which there are diagnosed 
pathological inflammation of the wall of the digestive 
tract as a result of inflammation caused by the influx of 
neutrophils into the lumen.  One of the reliable 
methods in the assessment of these changes is the 
endoscopic method. However, it belongs to invasive 
diagnostic methods. Therefore, it seems reasonable to 
seek for various markers that would facilitate diagnosis 
of the above diseases and constitute a useful tool in the 
differential diagnosis. A special role is attributed to the 
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